A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )
NCT01227551
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
57
Enrollment
INDUSTRY
Sponsor class
Conditions
Malignant Melanoma
Interventions
BIOLOGICAL:
Coxsackievirus A21 (CVA21)
Sponsor
Viralytics